Locus 141: PRODH (22q11.21)
| Meta-analysis summary statistics for associations meeting genome-wide significance |
| Lead SNP | Biochemicals | EA/OA | Ntotal | EAF | Effect (SE) | Pmeta | Details |
| rs2540647 |
valine / proline |
A/G |
7353 |
0.09 |
-0.059 (0.003) |
2.04·10-70 |
show |
| rs2540641 |
proline |
A/C |
7367 |
0.08 |
0.063 (0.004) |
2.98·10-59 |
show |
EA = effect allele; OA = other allele; EAF = frequency of effect allele;
| Summary of biological annotations |
| SNP | rs2540647 |
| Chromosomal location | Chr22: 17,346,617 (22q11.21) |
| Gene (distance) | PRODH (42,552) |
| Predicted causal gene | PRODH |
| Gene/protein classification | - |
| Metabolite (Pathway) | valine (Valine, leucine and isoleucine metabolism; Amino acid) proline (Urea cycle; arginine-, proline-, metabolism; Amino acid) |
| Biochemical locus-metabolite relationship | PRODH encodes proline dehydrogenase which catalyzes the first step in proline degradation [16874462]. Ratio interpretation: PRODH encodes proline dehydrogenase which catalyzes the first step in proline degradation. Valine may normalize for the amino acid pool ('normalizing'). |
| eQTL associations | PRODH (F), PRODH (S) † |
† F = adipose tissue; S = skin cells; L = lymphoblastoid cells; H = liver cells;
| Medical information |
| Complex trait associations | - |
| Known metabolite associations | proline [21886157]; Proline [23823483] |
| Inborn error of metabolism | Hyperprolinaemia type I |
| Pharmacological information |
| ChEMBL ID | - |
| Drug information |
-
|
| Locus information for top associated metabolite |
HapMap2 imputation | 1KGP imputation |

